Mankind Pharma to Consolidate BSVL Business via Voluntary Liquidation
Mankind Pharma approved a plan to consolidate its material wholly owned subsidiary Bharat Serums and Vaccines Limited (BSVL) into the parent via voluntary liquidation. At its board meeting on August 26, 2026, it noted BSVL’s decision and consented to expeditious consolidation, subject to regulatory approvals and licensing. BSVL’s business would transfer as a going concern, Appian would receive cash for its 4% stake, and BSVL would be dissolved under the Insolvency and Bankruptcy Code.